Incurix
PrivateLast Round
Grant
Dec 7, 2023
Company Overview
Incurix operates in Healthcare & Life Sciences and is based in Goyang-si. Its latest recorded funding round was a Grant round in December 2023.
Incurix is a drug discovery company that develops anticancer drugs designed for targeting tumor transcription factors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Incurix Comparables
Compare Incurix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MycRx | 87% | |
| WebenPharma | 84% | |
| Peptomyc | 78% |
For institutional investors. Book with your work email.
Incurix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 7, 2023 | ||||
| Grant | Sep 22, 2023 | ||||
| Series A | Mar 1, 2021 |
For institutional investors. Book with your work email.
Incurix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Drug Development Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 7, 2023
Received grant funding from the Korea Drug Development Fund.
- Sep 22, 2023
Received grant funding from Korea Drug Development Fund.
For institutional investors. Book with your work email.
Incurix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Incurix's valuation, stock price, and market status.
Is Incurix a public or private company?
Incurix is a private company.
What is the current stock price of Incurix?
Incurix is a private company, so its shares have no public market price. Caplight tracks Incurix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Incurix worth (valuation)?
Valuation information for Incurix is not publicly available.
Can I buy Incurix stock?
Incurix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Incurix's last funding round?
Incurix's most recent funding round was Grant on December 7, 2023.
Who are the main investors in Incurix?
Key investors in Incurix include Korea Drug Development Fund.
Will Incurix IPO soon?
No public IPO plans have been announced for Incurix.
How can I track Incurix secondary market activity?
Caplight tracks bids, offers, and trades in Incurix's shares on secondary markets.